Micro-X Cracks the US Market with Major Hospital Deal

South Australian tech company Micro-X has reached an important milestone, locking in its first supply deal with a leading United States healthcare provider. The agreement covers its Rover Plus mobile x-ray machine, and marks the company’s entry into the world’s biggest healthcare market.

This deal follows a competitive tender and in-hospital trials conducted in 2024. After proving its performance across four US hospitals, the Rover Plus has now been added to the buyer’s approved procurement list. That means individual hospitals in the network can now purchase the machines directly, without the need for further testing or internal reviews.

The customer’s name has not been disclosed, at their request. However, the announcement reveals that the buyer is one of the largest healthcare organisations in the United States, running more than 700 hospitals and medical facilities. These facilities care for over 8.5 million patients each year.

Micro-X says the agreement is a turning point. It covers standard terms including warranties, lead times and a tiered pricing structure. The deal is set for an initial term of three years. The company is also in talks with another major US procurement group, aiming to secure a second deal.

Chief Executive Officer Kingsley Hall said the agreement was a major win in a market that tends to stick with established brands. “The global healthcare market is generally conservative. It took nearly a year to build trust and show the value of Rover. This is a key step in our strategy to become a recognised medical imaging supplier,” he said.

Sales boss Scott Bryant added that getting on the approved list will allow Micro-X to meet the customer’s ongoing need for both new and replacement x-ray systems. “This outcome highlights the versatility and reliability of the Rover Plus. Our teams worked hard to reach this point, and we now look forward to our first orders,” he said.

The Rover Plus is part of a growing suite of high tech imaging products developed by Micro-X. Using a unique cold cathode technology, the machines are lighter, more portable and use less power than traditional x-ray systems. This makes them easier to use in tight spaces like hospital wards and field locations.

Micro-X has about $4 million worth of Rover Plus stock on hand and is preparing its supply chain for increased demand. While this first US deal is not exclusive and does not imply endorsement from the healthcare group, it clearly opens a door to a large and influential market.

With a technical base in Adelaide and a growing team in Seattle, Micro-X is one of the few Australian companies breaking into global medical and security imaging. If all goes to plan, this initial agreement could be the first of many.